Novartis India Ltd has informed BSE that the Company will publish audited accounts for the financial year ended March 31, 2009. Accordingly, the Company shall not publish the Unaudited Financial Results (Provisional) of the Company for the quarter ended March 31, 2009.
Now the offer price from 20/5 to 8/6/09 seems at the same old price, under the circumstances can one expect a higher price than the CMP ? or would the buying be done at prevailing market prices during the period 20/5 to 8/6/09 ? In that case the market price may go up much higher, what should be the strategy henceforth ?
You are right. The imbeciles on behalf of those who want to acquire Share go on phoning from phone No 2240306015 enquiring why the shareholders have not tendered their shares in the
Novartis increases its offer price on Novartis India Ltd.
This release is neither an offer to purchase nor a solicitation of an offer to sell shares of Novartis India Ltd.
Basel, Switzerland, May 28, 2009 - Novartis announced today an increase in the offer price for Novartis India Ltd. to Rs 450 per share, from Rs 351 initially proposed.
The revised offer represents a premium of 63% to the closing share price of Rs 275.6 of Novartis India Ltd. on March 24, which was the last trading day before announcement of the offer.
This proposal represents Novartis` only and final price revision to this offer, as May 28 is the last day on which the price can be revised.
Can anyone tell me what would be strategy for NOVARTIS Shareholder after increase in open offer price to Rs.450.Should investor tender share in open offer for Rs.450 or it is better to hold for long term hoping that either offer price or market price of novartis shares will increase? What are the chances that after open offer closes in june that current market price around rs.444 will be sustained or it will fall below rs.400?
| NIFTY 
